Authors find that the provision of NEMT to those who currently lack it results in a net cost savings across the transportation and health care domains for four of these conditions (prenatal care, asthma, heart disease, and diabetes) and is cost-effective for the remaining eight conditions (influenza vaccinations, breast cancer screening, colorectal cancer screening, dental care, chronic obstructive pulmonary disease, hypertension, depression, and end-stage renal disease). These cost-effectiveness analyses take into account increased life expectancy and improved quality of life and indicate that the provision of additional transportation is worth the investment for these eight conditions. On the basis of these findings, it was concluded that the provision of NEMT to those transportation-disadvantaged individuals who lack access to it would result in net societal benefits for all 12 conditions examined.
FocusCancerCardiovascular DiseaseCost EffectivenessDiabetesPreventive CareTransportation as a Barrier to Care
Line of Business or Market